A joint effort between the startup Owkin and Actelion Pharmaceuticals, one of the Janssen companies, will seek to develop…
Articles by Marisa Wexler, MS
Regularly consuming low-alcohol red wine reduced signs of pulmonary arterial hypertension (PAH) in a rat model of the disease,…
As part of the company’s Pulmonary Hypertension Accelerated Bayer (PHAB) Awards, Bayer is giving a total of $1 million…
Apabetalone (RVX-208), Resverlogix‘s experimental treatment for pulmonary arterial hypertension (PAH), was well-tolerated in a small clinical trial, the…
For premature babies who are at high risk of pulmonary hypertension (PH) and other cardiovascular complications, consuming human breast milk…
Early treatment with Janssen’s Uptravi (selexipag) can halve the risk of disease progression for people with pulmonary arterial…
Cereno Scientific is planning to begin a Phase 2 clinical trial of CS1 — the company’s lead therapy candidate…
Levosimendan, an investigational treatment for pulmonary hypertension and heart failure with preserved ejection fraction, or PH-HFpEF — which…
In late July, the U.S. Food and Drug Administration (FDA) approved a new formulation of Janssen‘s Uptravi (selexipag) for…
The U.S. Food and Drug Administration (FDA) has approved an intravenous form of Uptravi (selexipag) — one infused directly into the…
A protein called TIFA is elevated in the blood cells of people with pulmonary arterial hypertension (PAH), suggesting this…
An upcoming series of educational virtual events for people with pulmonary arterial hypertension (PAH) and their caregivers will offer…